4h
Zacks Investment Research on MSNIs Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What ...
The Canadian biotech firm will focus on "maximizing shareholder value" as it offloads its core business following months of ...
Additionally, Unity Biotechnology also announced 3 Yehia Hashad, MD, executive vice president of research and development and ...
Arizona State Retirement System lessened its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 6.3% in the 4th ...
London (AFP) | 17/03/2025 - 14:59:21 | UK pledges up to £160 million for Syria's post-Assad recovery ...
The approach isn't new. App developers sometimes seek financial support from avid users and medical research institutions ...
4d
Zacks Investment Research on MSNIs Franklin Biotechnology Discovery A (FBDIX) a Strong Mutual Fund Pick Right Now?There are plenty of choices in the Sector - Health category, but where should you start your research? Well, one fund that might be worth investigating is Franklin Biotechnology Discovery A (FBDIX).
What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing position in the biotechnology race with China has broader implications than just ...
5d
Daily Times(PK) on MSNPromise and Perils of biotechnology for national securityBiotechnology has been in use by humans for over 10,000 years. Ancient bioscience incorporated processes like fermentation ...
This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...
VIR's T-cell engagers have potential in oncology and showed promise with initial data in January 2025. Read my thoughts about ...
Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 5.6% in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results